Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing antibodies

Details for Australian Patent Application No. 2006210792 (hide)

Owner The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services The Johns Hopkins University

Inventors Gambhira, Ratish; Roden, Richard B. S.; Schiller, John T.; Pastrana, Diana V.; Lowy, Douglas R.

Agent FB Rice

Pub. Number AU-B-2006210792

PCT Pub. Number WO2006/083984

Priority 60/697,655 07.07.05 US; 60/649,249 01.02.05 US; 60/752,268 21.12.05 US

Filing date 1 February 2006

Wipo publication date 10 August 2006

Acceptance publication date 26 July 2012

International Classifications

C07K 14/025 Peptides having more than 20 amino acids

A61K 39/12 Medicinal preparations containing antigens or antibodies - Viral antigens

C12N 15/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/083984 Priority application(s): WO2006/083984

26 July 2012 Application Accepted

  Published as AU-B-2006210792

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006210793-Systems and methods for controlling use of power in a computer system

2006210791-Bridgehead radiolabelled compounds and methods of using the same